Published on Web 07/21/2007
Enantioselective Friedel-Crafts Alkylations Catalyzed by
Bis(oxazolinyl)pyridine-Scandium(III) Triflate Complexes
David A. Evans,* Keith R. Fandrick, Hyun-Ji Song, Karl A. Scheidt, and Risheng Xu
Contribution from the Department of Chemistry and Chemical Biology, HarVard UniVersity,
Cambridge, Massachusetts 02138
Received April 27, 2007; E-mail: evans@chemistry.harvard.edu
Abstract: The enantioselective Friedel-Crafts addition of a variety of indoles catalyzed by bis(oxazolinyl)-
pyridine-scandium(III) triflate complexes (Sc(III)-pybox) was accomplished utilizing a series of â-substituted
R,â-unsaturated phosphonates and R,â-unsaturated 2-acyl imidazoles. The acyl phosphonate products
were efficiently transformed into esters and amides, whereas the acyl imidazole adducts were converted
to a broader spectrum of functionalities such as esters, amides, carboxylic acids, ketones, and aldehydes.
The sense of stereoinduction and level of enantioselectivity were found to be functions of the size of the
substrate employed, the substitution on the ligand, and the catalyst loading. Molecular modeling of the
catalyst with the bound substrates was performed based on the crystal structures of the catalyst complexes
and the sense of stereoinduction observed in the addition reaction. Nonlinear effects over a range of catalyst
concentrations implicate a mononuclear complex as the active catalyst.
Introduction
The Friedel-Crafts reaction and its enantioselective variants
are powerful carbon-carbon bond forming transformations in
organic chemistry.1 Due to the prevalence of the indole nucleus
in both natural products2 and potential medicinal agents,3
considerable effort has been extended in the development of
enantioselective alkylation reactions between this important
heterocycle and R,â-unsaturated carbonyl compounds.4 This
investigation documents our studies directed toward the devel-
opment of the chiral scandium(III)-pybox complex 1a for the
enantioselective alkylation of the indole and pyrrole nuclei, and
related electron-rich heteroaromatic substrates, with compatible
R,â-unsaturated carbonyl derivatives.
This investigation has focused on the evaluation of both
substrate structure, its chelating potential (eqs 1, 2), and catalyst
architecture for the development of an effective enantioselective
alkylation process.
Jørgensen was the first to extrapolate the Cu(II) chelation
motif in exploring this reaction utilizing our Cu(II)-bis-
(oxazoline) catalyst with R-keto esters and alkylidene malonates
(eqs 3, 4).5 Tang later improved on the use of arylidene
malonates in the Friedel-Crafts reaction by utilizing trisox-
azoline Cu(II) complexes.6 Concurrently, Umani-Ronchi re-
ported the addition reaction on two fronts: first, with the use
of R,â-unsaturated thioesters with a Pd(II)-(Tol-binap) catalyst,
and second, by designing a single-point binding catalyst for this
important transformation.7 During this present investigation,
Palomo demonstrated that R′-hydroxy enones are also competent
(1) For a review of the Friedel-Crafts reaction, see: Olah, G. A.; Krishnamurti,
R.; Prakash, G. K. S. Friedel-Crafts Alkylations. In ComprehensiVe
Organic Synthesis; Trost, B. M., Fleming, I., Eds.; Pergamon Press: Oxford,
1991; Vol. 3, pp 293-339.
(2) For examples of natural products which are relevant to the formed
stereocenter, see: cycloaplysinopsin (a) Mancini, I.; Guella, G.; Zibrowius,
H.; Pietra, F. Tetrahedron 2003, 59, 8757-8762. 10,11-Dimethoxynare-
line: (b) Kam, T.; Choo, Y. J. Nat. Prod. 2004, 67, 547-552. Hapalin-
doles: (c) Kinsman, A. C; Kerr, M. A. J. Am. Chem. Soc. 2003, 125,
14120-14125. (d) Huber, U.; Moore, R. E.; Patterson, G. M. L. J. Nat.
Prod. 1998, 61, 1304-1306.
(3) For examples of potential medicinal agents relevant to the formed
stereocenter, see: (a) Rawson, D. J.; Dack, K. N.; Dickinson, R. P.; James,
K. Bioorg. Med. Chem. Lett. 2002, 12, 125-128. (b) Dillard, R. D., et al.
J. Med. Chem. 1996, 39, 5119-5136. (c) Chang-Fong, J.; Rangisetty, J.
B.; Dukat, M.; Setola, V.; Raffay, T.; Roth, B.; Glennon, R. Bioorg. Med.
Chem. Lett. 2004, 14, 1961-1964.
(4) For a review of the asymmetric Friedel-Crafts reaction, see: Bandini, M.;
Melloni, A.; Umani-Ronchi, A. Angew. Chem., Int. Ed. 2004, 43, 550-
556.
(5) (a) Jensen, K. B.; Thorhauge, J.; Hazell, R. G.; Jørgensen, K. A. Angew.
Chem., Int. Ed. 2004, 40, 160-163. (b) Zhuang, W.; Hansen, T.; Jørgensen,
K. A. Chem. Commun. 2001, 347-348. For a review on the use of Cu-
(II)-bis(oxazoline) catalysts, see: (c) Johnson, J. S.; Evans, D. A. Acc.
Chem. Res. 2000, 33, 325-335.
(6) (a) Zhou, J.; Tang, Y. Chem. Commun. 2004, 432-433. (b) Zhou, J.; Ye,
M.-C.; Huang, Z.-Z.; Tang, Y. J. Org. Chem. 2004, 69, 1309-1320.
9
10.1021/ja072976i CCC: $37.00 © 2007 American Chemical Society
J. AM. CHEM. SOC. 2007, 129, 10029-10041
10029